Johns Hopkins University-Sidney Kimmel Cancer Center
401 North Broadway
Baltimore, Maryland 21287
410-955-5000 http://www.hopkinsmedicine.org/kimmel_cancer_center/

Use our guide to learn which trials are right for you!

The name Johns Hopkins has become synonymous with excellence in research and patient care. Its science and medical programs earn more federal research dollars than any other medical institution in the country.

Since its opening in 1973, our Cancer Center has led the world in deciphering the mechanisms of cancer and new ways to treat it. The strength of our research and treatment programs was recognized early on by the National Cancer Institute, becoming one of the first to earn comprehensive cancer center status and recognition as a "Center of Excellence."

One of only 41 cancer centers in the country designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center, the Johns Hopkins Kimmel Cancer Center has active programs in clinical research, laboratory research, education, community outreach, and prevention and control. The Kimmel Cancer Center is the only Comprehensive Cancer Center in the state of Maryland. More on the NCI's Cancer Centers Program, including a locator map.

We've found
100 trials
at this facility
Hematology, Oncology, Reproductive Clinical Trial
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 1/12/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
Status: Enrolling, Phase I
Updated: 2/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab, Nivolumab, and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I
Updated: 3/14/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Adult Acute Myeloid Leukemia in Remission Clinical Trial
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/31/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
WEE1 Inhibitor AZD1775, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme
Status: Enrolling, Phase I
Updated: 3/31/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Status: Enrolling, Phase III
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling, Phase III
Updated: 1/26/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Malignant Digestive System Neoplasm Clinical Trial
Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
Status: Enrolling, Phase I
Updated: 2/15/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Status: Enrolling, Phase II
Updated: 3/16/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Status: Enrolling
Updated: 3/22/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Trial
Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 1/7/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Status: Enrolling, Phase I, II
Updated: 1/15/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
Status: Enrolling, Phase II
Updated: 2/2/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase I
Updated: 2/24/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 2/24/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 3/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Adult Brain Glioblastoma Clinical Trial
Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
Status: Enrolling, Phase II
Updated: 3/8/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Status: Enrolling, Phase I
Updated: 3/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Status: Enrolling, Phase I
Updated: 3/14/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 1/29/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Stereotactic Radiosurgery and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine
Status: Enrolling, Phase I
Updated: 3/23/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
Status: Enrolling, Phase I, II
Updated: 3/29/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase I, II
Updated: 3/7/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Status: Enrolling, Phase II
Updated: 3/7/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic or Unresectable Sarcoma
Status: Enrolling, Phase II
Updated: 3/21/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Trial
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Status: Enrolling, Phase III
Updated: 3/25/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
Status: Enrolling, Phase I, II
Updated: 3/25/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
Status: Enrolling, Phase II
Updated: 3/30/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Trial
MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer
Status: Enrolling, Phase II
Updated: 1/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology, Oncology Clinical Trial
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction
Status: Enrolling, Phase I
Updated: 1/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 1/14/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Status: Enrolling, Phase II, III
Updated: 2/9/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Status: Enrolling, Phase II, III
Updated: 2/18/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Familial Adenomatous Polyposis Clinical Trial
Curcumin in Treating Patients With Familial Adenomatous Polyposis
Status: Enrolling, Phase II
Updated: 3/1/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Recurrent Small Cell Lung Carcinoma Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 3/9/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Status: Enrolling, Phase I
Updated: 3/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 3/29/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase I
Updated: 1/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Status: Enrolling, Phase II
Updated: 1/18/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Juvenile Myelomonocytic Leukemia Clinical Trial
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 1/19/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
Status: Enrolling, Phase I
Updated: 3/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
Status: Enrolling, Phase II
Updated: 3/16/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
Status: Enrolling, Phase II, III
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 4/4/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Untreated Adult Acute Myeloid Leukemia Clinical Trial
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 2/18/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
Status: Enrolling, Phase II
Updated: 2/19/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Oncology, Other, Reproductive Clinical Trial
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
Status: Enrolling, Phase I
Updated: 3/10/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Status: Enrolling, Phase II
Updated: 3/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Trial
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Status: Enrolling, Phase III
Updated: 3/11/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
TORC1/2 Inhibitor INK128 Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 3/22/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Desmoid-Type Fibromatosis Clinical Trial
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Status: Enrolling, Phase III
Updated: 3/31/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer
Status: Enrolling, Phase I
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II, III
Updated: 3/25/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Status: Enrolling, Phase II
Updated: 3/25/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Other Clinical Trial
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Status: Enrolling
Updated: 2/19/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Adult Solid Neoplasm Clinical Trial
Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies
Status: Enrolling, Phase I
Updated: 1/22/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials